Each month in his online column, Dr Andrade offers practical knowledge, ideas, and tips in psychopharmacology to JCP readers in psychiatric and general medical settings.
Evidence for Delayed Transit of Tablets Through the Esophagus
Nearly 4 decades ago, Evans and Roberts 7 remarked that the sensation of swallowed tablets "sticking" in the esophagus is common; in fact, one of the authors had personally experienced dysphagia after ingesting an antimalarial tablet. These authors therefore conducted a simple study to determine how often tablets stick in the esophagus and the site at which the tablets lodge. They 7 administered barium sulfate tablets to 98 consecutive patients (57% male) who were undergoing a routine radiologic study of the gastrointestinal tract; no patient had known obstructive esophageal disease. The tablets were identical in size and shape to the common aspirin tablet. Each patient received 2 tablets along with just enough water (15 mL) to assist swallowing. The patients were asked to lie down immediately after swallowing the tablets and were subjected to fluoroscopic examination in the supine position. If the tablets remained in the esophagus for more than 5 minutes, the patients were asked to stand and were then reexamined at 10-minute intervals until the tablets entered the stomach.
The findings of the study 7 are summarized in Table 1 . Esophageal retention of tablets for > 5 minutes was observed in 58% of the sample. Upper gastrointestinal disease was a risk factor for tablet retention; however, tablet retention was also observed in more than half of patients with a normal esophageal study. Of the 2 patients with the longest esophageal transit time, 1 had no radiologic diagnosis (transit time = 45 minutes), and the other had an esophageal stricture (transit time = 90 minutes).
Evans and Roberts 7 reported that they also had evidence of esophageal retention of capsules and of tablets smaller than the ones administered in their study. A limitation of their study is that it was conducted in patients who had been referred for radiologic investigation and who, consequently, would be more likely to show tablet retention. Another limitation is that the patients had been allowed only 15 mL of water to help them swallow their tablets. A strength of this study is that it illustrates risks in patients with known or suspected upper gastrointestinal disease and in those who habitually swallow their medications with little or no water and who lie down afterward.
Implications of Delayed Transit Through the Esophagus
Esophageal retention of a swallowed pill will delay absorption and hence the onset of action of the medication. This issue may not be clinically relevant with most medications and in most situations, particularly in psychiatric practice. More importantly, if a pill is lodged in the esophagus, it may cause local irritation and ulceration. This condition is known as pill-induced esophagitis or just pill esophagitis, an underreported condition that is well known to gastroenterologists and underrecognized by other medical specialists. [8] [9] [10] Patients who experience pill esophagitis commonly only suffer sudden-onset retrosternal pain. Although this pain is usually self-limiting, it can persist for several days in association with dysphagia. In some cases, esophageal hemorrhage, stricture, and perforation may occur, and fatality is a rare but possible outcome. [8] [9] [10] Iron-containing medications have long been known to cause pill esophagitis. Initiation or exacerbation of esophageal and gastric lesions by iron has been histologically demonstrated, 11, 12 and fatality has been reported. 11 In a prospective endoscopic study of the upper gastrointestinal tract, Kaye et al 13 found that 15 of 93 (16%) patients receiving oral iron tablets had iron deposits evident on routine hematoxylin and eosin staining. Pooling these with data obtained from a retrospective data set, they found that, of patients with esophageal iron deposit, 6 of 7 (86%) had associated erosion; of patients with gastric iron deposit, 29 of 46 (63%) had erosion and 37 (80%) had reactive gastritis.
Other pills that can cause painful erosions if they lodge temporarily in the esophagus include those that contain aspirin or nonsteroidal anti-inflammatory drugs, alendronate, doxycycline, tetracycline, macrolide antibiotics, antimalarials, and potassium. [8] [9] [10] 14 In psychiatry, pill esophagitis has been reported with fluoxetine. 15 In fact, a large review 8 described pill esophagitis in association with nearly a hundred different medications in 979 patients. The management of pill esophagitis was summarized by Kikendall.
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Risk Factors for Pill Esophagitis
In a histopathologic study of 12 patients with ironrelated esophageal ulceration, Serck-Hanssen and Stray 11 observed that all patients were elderly and most were bedridden. Greater age may be associated with less efficient esophageal motility, and gravitational assistance to esophageal transit of medication might be diminished in the supine position. Thus, greater age and supine posture may be 2 predispositions to pill esophagitis. 9 Patients in the Evans and Roberts 7 study ingested their tablets with very little water; this, therefore, is also likely to be a risk factor. 9 The authors 7 showed that esophageal retention of tablets is common even in patients who are upright after the first 5 minutes; one wonders how much more frequent If pills are swallowed with little or no water, or if the ■ patient lies down immediately after swallowing the pills, esophageal transit of the pills may be delayed; this can cause pill esophagitis, a preventable condition that is commoner in elderly subjects. Pill esophagitis can also occur in conditions associated with ■ narrowing of the esophageal lumen. Pill esophagitis is more likely with medications such as iron, alendronate, aspirin, anti-inflammatory drugs, antibiotics, and antimalarials. The risk of pill esophagitis can be reduced by swallowing ■ the pill with sufficient water, taking the pill before or during a meal, and staying upright for 15-30 minutes after pill ingestion. If these precautions are difficult to follow, administration of liquid formulations, orodispersible tablets, or crushed tablets can lower the risk. had a 72% tablet retention rate. Patients with a normal esophageal study (n = 69) had a 52% retention rate. 6. Only 2 patients were aware that the tablets had remained in the esophagus, and both had esophageal stricture. a Data from Evans and Roberts. or prolonged the retention might have been if the patients were supine throughout the period of observation. Given that the patients were required to lie supine for the first 5 minutes, another possible implication is that once a tablet is impacted in the esophagus, it is not easily dislodged. This suggests the need for patients to remain upright for a short while after swallowing a tablet or capsule.
Anything that physically or physiologically impairs esophageal transit could increase the risk of pill esophagitis. Examples include disorders of esophageal motility, left atrial enlargement with resultant esophageal compression, hiatus hernia, and esophageal stricture. [8] [9] [10] 14 Pill esophagitis may also be commoner with capsules, sustained-release formulations, and large or oddly shaped pills.
10
Guidance
Given the literature that has been reviewed, the following recommendations are reasonable [7] [8] [9] [10] :
Tablets and capsules should be swallowed with 1.
a full glass of water so that the water will carry the medication into the stomach along with the peristaltic waves. Tablets and capsules should be ingested before or 2.
during a meal rather than after the meal so that the food will mechanically carry the medication into the stomach along with the peristaltic waves. This recommendation, of course, will not apply to medications that are specifically advised to be taken on an empty stomach; thyroxine is one such example. 16 Patients should not lie down for at least 15-30 3.
minutes after ingesting a tablet or capsule; peristaltic movement of the medication into the stomach may be aided by gravity if the medication has not already entered the stomach with the assistance of water and food, as described above. Patients receiving hypnotic drug therapy are usually asked to go to bed immediately after taking their medication. Whereas hypnotic drugs have not generally been associated with pill esophagitis, it could be good practice even for such patients to wait for about 5 minutes before lying down. These recommendations are especially relevant to 4.
medications that can damage the esophagus, such as iron, aspirin, anti-inflammatory drugs, alendronate, potassium, tetracyclines, macrolide antibiotics, and antimalarials. [8] [9] [10] In some patients, these recommendations may not 5.
be implementable. For example, patients receiving electroconvulsive therapy (ECT) are allowed only a sip of water when they take their essential medications on the morning of an ECT session. Or, patients who are confined to bed may not be able to drink much or eat, nor may they be able to remain upright after ingesting their medications. Therefore, wherever possible, such patients should receive liquid, chewable, or mouth-dissolving (orodispersible) formulations or formulations that can be crushed before administration with water.
Concluding Notes
Pill esophagitis is a preventable condition. Providing the necessary guidance to the patient in order to minimize the risk of this condition should take less than a minute.
